← Leaderboards
Karin Przyklenk
Good Samaritan Hospital
$3,761,991
Attributed
$3,761,991
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $585.9K · FY2007–12$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,761,991 · 4
By mechanism
R01$3,024,876 · 2
R56$393,750 · 1
R21$343,365 · 1
Top collaborators
No co-investigators on record.
Most similar at Good Samaritan Hospital
Same institution · by research overlap
- Robert A Kloner$2,963,450
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorAdenosineIschemic PreconditioningMaintenanceFailure (Biologic Function)LaboratoriesMediatingFutureHospitalizationInsightClopidogrelCoronaryAnimal ModelBlood PlateletsEventIschemiaAspirinDesignAttenuationAcuteAgonistInfarctionAcute Coronary SyndromeMolecular
Grant awards (15)
Preconditioning improves coronary patency$338,580
R01 · FY2012 · HL · contact PI
Preconditioning improves coronary patency$342,000
R01 · FY2011 · HL · contact PI
Preconditioning improves coronary patency$342,000
R01 · FY2010 · HL · contact PI
Preconditioning improves coronary patency$333,680
R01 · FY2009 · HL · contact PI
Aging, Adenosine and Platelet-Mediated Thrombosis$151,177
R21 · FY2008 · AG · contact PI
Preconditioning Improves Coronary Patency$304,375
R56 · FY2007 · HL · contact PI
Aging, Adenosine and Platelet-Mediated Thrombosis$192,188
R21 · FY2007 · AG · contact PI
Preconditioning Improves Coronary Patency$89,375
R56 · FY2007 · HL · contact PI
Preconditioning Improves Coronary Patency$278,250
R01 · FY2004 · HL
Role of inositol trisphosphate in preconditioning$278,250
R01 · FY2004 · HL
Preconditioning Improves Coronary Patency$278,250
R01 · FY2003 · HL
Role of inositol trisphosphate in preconditioning$278,250
R01 · FY2003 · HL
Preconditioning Improves Coronary Patency$277,666
R01 · FY2002 · HL
Role of inositol trisphosphate in preconditioning$260,767
R01 · FY2002 · HL
Role of inositol trisphosphate in preconditioning$17,183
R01 · FY2002 · HL